IP Library Granted Patent US 10,030,065
Granted Patent B2
US 10,030,065 · App. 12/644,554 · Granted Jul 24, 2018

MHC multimers, methods for their generation, labeling and use

Inventors: Liselotte Brix (Bagsværd, DK); Henrik Pedersen (Lynge, DK); Tina Jakobsen (Ballerup, DK); Jørgen Schøller (Lyngby, DK); Jesper Lohse (Coenhagen NV, DK); Katja Brunstedt (Lyngby, DK); Kivin Jacobsen (Hvalsø, DK)
Assignee: Dako Denmark A/S
C07K14/70539A61K47/61A61K47/6425A61K47/665B82Y5/00A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,030,065
App. No.
12/644,554
Granted
Jul 24, 2018
Kind
B2
Abstract

The present invention relates to a soluble negative control MHC multimer comprising a nonsense peptide that binds the MHC protein efficiently, but that does not support binding of the resultant MHC-peptide complex to the desired T Cell Receptor. The nonsense peptide is designed to i) have a length enabling binding to the MHC allele in question, ii) have appropriate amino acids at relevant anchor positions which anchor the nonsense peptide to the peptide-binding groove of the MHC, iii) have amino acids outside the anchor positions that do not support binding to a T Cell Receptor, and iv) have an amino acid sequence that is different from the linear sequence of any naturally occurring peptide.

Claims (14)

1. A soluble MHC multimer comprising (a-b-P) n , wherein n>1;

wherein a and b together form a functional MHC protein capable of binding nonsense peptide P;

wherein (a-b-P) is an MHC-peptide complex formed when P binds to the functional MHC protein;

wherein the functional MHC protein is HLA-A*0201:

wherein each MHC peptide complex of the multimer is associated with one or more multimerization domains;

and

wherein said nonsense peptide P is GLAGDVSAV (SEQ ID NO:11) or ALIAPVHAV (SEQ ID NO:12).

2. The soluble MHC multimer according to claim 1 , wherein the one or more multimerization domains comprise one or more polysaccharides.

3. The soluble MHC multimer according to claim 1 , wherein the one or more multimerization domains comprise one or more dextran moieties.

4. A composition comprising a plurality of soluble MHC multimers according to claim 1 , wherein the MHC multimers are identical or different, and a carrier.

5. The soluble MHC multimer according to claim 1 , wherein said one or more multimerization domains are soluble polysaccharides.

6. The soluble MHC multimer according to claim 5 , wherein said soluble polysaccharides are soluble dextrans.

7. The soluble MHC multimer according to claim 1 , wherein one or more labels are attached directly to the MHC multimer.

8. The soluble MHC multimer according to claim 1 , wherein one or more labels are attached indirectly to the MHC multimer via one or more marker molecules carrying one or more labels.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2020
From: DAKO DENMARK APS
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 051629/0162 →
CHANGE OF NAME Recorded Jan 27, 2020
From: DAKO DENMARK A/S
To: DAKO DENMARK APS
Reel/Frame 051708/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2010
From: BRIX, LISELOTTE; PEDERSEN, HENRIK; JAKOBSEN, TINA; SCHOLLER, JORGEN; LOHSE, JESPER; BRUNSTEDT, KATJA; JACOBSEN, KIVIN
To: DAKO DENMARK A/S
Reel/Frame 023936/0084 →
Priority Claims (4)
DK 2007 00972 · Jul 3, 2007 · national
DK 2007 00973 · Jul 3, 2007 · national
DK 2007 00974 · Jul 3, 2007 · national
DK 2007 00975 · Jul 3, 2007 · national
Continuity (6)
Continuation PCTDK2008050167 · Jul 3, 2008
Provisional Application 60929586 · Jul 3, 2007
Provisional Application 60929582 · Jul 3, 2007
Provisional Application 60929581 · Jul 3, 2007
Provisional Application 60929583 · Jul 3, 2007
Related Publication 20100168390A1 · Jul 1, 2010
Cited By (1)
US 12,352,719